imfinzi.com

IMFINZI® (durvalumab) is an immunotherapy approved to treat patients with unresectable hepatocellular carcinoma, bile duct cancer, gallbladder cancer, unresectable Stage 3 NSCLC, Stage 4 NSCLC, and extensive-stage SCLC.

Rank
most trending domain overall The website you are looking for didn't make it to the trending list.
Is this your site? Pimp your SEO with mangools SEO tools.
Rank Rank Rank Rank

Popularity

Website popularity rank trend

Day:
Week:
Month:

Social reach

Facebook shares trend

Day:
Week:
Month:

Referring domains trend

Day:
Week:
Month: